Recombinant antigen to be used in the diagnosis of canine Leishmaniasis

Project 20

Problem to be solved:
• Elimination of infected dogs by leishmania
• Difficulties in identifying the disease in dogs

Proposed Innovation:
• Recombinant antigen to be used in rapid diagnostic test of canine Leishmaniasis

Differential:
• In field or laboratory use
• Simple execution with fast results
• Distinction between vaccinated and infected dogs
• Reduction in the number of improper euthanasia
• Optimization of preventive measures to control the disease in humans

Development status:
Prototype

Intellectual property status:
BRPI0900961-2 (corresponding PCT filed)

What we want
Partnership

Coordinator:
Patricia Sampaio Tavares Veras / CPqGM

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br